Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders


Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Editorial [Hot topic: Brave New World? Arrestin Pathway Bias in Drug Design (Guest Editor: Bradley T. Andresen)] promotion: free to download

Volume:11   Issue: 2
Pp: 90-91
Bradley T. Andresen and Louis M. Luttrell
DOI: 10.2174/187153011795564142

A Pharmacological Primer of Biased Agonism open access plus

Volume:11   Issue: 2
Pp: 92-98
Bradley T. Andresen
DOI: 10.2174/187153011795564179

Advanced Glycation Endproducts and Diabetes. Beyond Vascular Complications

Volume:11   Issue: 2
Pp: 132-140
Alessandra Puddu and Giorgio L. Viviani
DOI: 10.2174/187153011795564115

Approaches to the Pharmacological Modulation of Plasmacytoid Dendritic Cells

Volume:11   Issue: 2
Pp: 154-164
Dorit Fabricius and Bernd Jahrsdorfer
DOI: 10.2174/187153011795564205

The Role of Eosinophils in Non-Parasitic Infections

Volume:11   Issue: 2
Pp: 165-172
Stefanie N. Linch and Jeffrey A. Gold
DOI: 10.2174/187153011795564188

The Search for Immunosuppressive Therapies to Induce Tolerance in Organ Transplantation

Volume:11   Issue: 2
Pp: 173-180
Kuei-Chen Chiang, Naoya Ohmori and Takeshi Goto
DOI: 10.2174/187153011795564197